MarketsNotableSingle-sourceDeveloping
5.1
Barinthus Biotherapeutics receives notice of non-compliance with Nasdaq listing standards
SEC EDGAR 8-K FilingsLO·GB · US·about 16 hours ago
Aimei Health Technology has filed an 8-K disclosing a notice of delisting or failure to satisfy continued listing standards. The specific regulatory deficiency remains undisclosed in the filing, signaling potential liquidity or compliance risks for the equity.